Home/Pipeline/Drug Development Program

Drug Development Program

Rare Diseases (unspecified)

Pre-clinicalDevelopment

Key Facts

Indication
Rare Diseases (unspecified)
Phase
Pre-clinical
Status
Development
Company

About MindMaze Therapeutics

MindMaze Therapeutics has established itself as a leader in developing integrated neurotherapeutic combinations, merging behavior, software, devices, and data analytics into a cohesive treatment ecosystem. The company's commercially available platform, including MindMotion GO and the MindPod immersive gaming environment, is already impacting patient lives through deployments in clinical and home settings. With a focus on precision neurotherapeutics for rare diseases and a robust pipeline of digital motion assessment tools, MindMaze is redefining brain health recovery by leveraging proprietary technology to capture and analyze digital biomarkers.

View full company profile